Co-Diagnostics (CODX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CODX Hot Sheet
Join SI Premium – FREE
Co-Diagnostics (NASDAQ: CODX) reported Q3 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $641.14 thousand versus the consensus estimate of $375 thousand.
For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investing.com’s stocks of the week
- Freedom Broker Downgrades PBF Energy (PBF) to Sell
- Stellantis NV (STLA) PT Lowered to $7.50 at Freedom Broker
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
